Organ loci of catabolism of short truncations of apoB

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1032-1038

  Zhu, Xian Feng ^a   Noto, Davide ^b   Seip, Rick ^c   Shaish, Aviv ^a   Schonfeld, Gustav ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF NEBRASKA AT KEARNEY   (United States)

Author keywords

apoB; apoB truncations; Dilactitol tyramine; Lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; IODINE 125; IODINE 131; LACTITOL; LOW DENSITY LIPOPROTEIN RECEPTOR; TYRAMINE;

ANIMAL MODEL; ARTICLE; FAMILIAL DISEASE; HYPOBETALIPOPROTEINEMIA; HYPOLIPEMIA; LIPOPROTEIN METABOLISM; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; RABBIT;

EID: 0030999283     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1032     Document Type: Article

References (37)

1. Schonfeld G. The hypobetalipoproteinemias. Ann Rev Nutr. 1995;15:23-34.
2. Ricci B, Sharp D, O'Rourke E, Kienzle B, Blinderman L, Gordon D, Smith-Monroy C, Robinson G, Gregg RE, Rader DJ, Wetterau JR. A 30-amino acid truncation of the microsomal triglyceride transfer protein large subunit disrupts its interaction with protein disulfide-isomerase and causes abetalipoproteinemia. J Biol Chem. 1995;270: 14281-14285.
3. Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wagersmith K, Gil CM, Turck CW, Bouma ME, Rader DJ, Aggerbeck LP, Gregg RE, Gordon DA, Wetterau JR. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinemia. Nature. 1993;365:65-69.
4. Shoulders CC, Brett DJ, Bayliss JD, Narcisi TME, Jarmuz A, Grantham TT, Leoni PRO, Bhattacharya S, Pease RJ, Cullen PM, Levi S, Byfield PGH, Purkiss P, Scott J. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet: 1993;2: 2109-2116.
5. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmilz J, Gay G, Rader DJ, Gregg RE. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992;256:999-1001.
6. Roy CC, Levy E, Green PHR, Sniderman A, Letarte J, Buts JP, Orquin J, Brochu P, Weber AM, Morin CL, Marcel Y, Deckelbaum RJ. Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B; chylomicron retention disease. Gastroenterology. 1987;92:390-399.
7. Patel S, Pessah M, Beucler I, Navarro J, Infante R. Chylomicron retention disease: exclusion of apolipoprotein-B gene defects and detection of mRNA editing in an affected family. Atherosclerosis. 1994;108:201-207.
8. Linton MF, Farese RV Jr, Young SG. Familial hypobetalipoproteinemia. J Lipid Res. 1993;34:521-541.
9. Young SG, Pullinger CR, Zysow BR, Hofmannradvani H, Linton MF, Farese RV, Terdiman JF, Snyder SM, Grundy SM, Vega GL, Malloy MJ, Kane JP. Four new mutations in the apolipoprotein-B gene causing hypobetalipoproteinemia, including 2 different frameshift mutations that yield truncated apolipoprotein-B proteins of identical length. J Lipid Res. 1993;34:501-507.
10. Schonfeld G. Inherited disorders of lipid transport. Endocrinol Metab Clin North Am. 1990;19:229-257.
11. Welty FK, Ordovas J, Schaefer EJ, Wilson PWF, Young SG. Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels. Circulation. 1995;92:2036-2040.
12. Averna M, Seip RL, Mankowitz K, Schonfeld G. Postprandial lipemia in subjects with hypobetalipoproteinemia and a single intestinal allele for apoB-48. J Lipid Res. 1993;34:1957-1967.
13. Leppert M, Breslow JL, Wu L, Hasstedt S, O'Connell P, Lathrop M, Williams RR, White R, Lalouel JM. Interference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindred. J Clin Invest. 1988;82:847-851.
14. Hobbs HH, Leitersdorf E, Leffert CC, Cryer DR, Brown MS, Goldstein JL. Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors. J Clin Invest. 1989;84:656-664.
15. Fazio S, Sidoli A, Vivenzio A, Maietta A, Giampaoli S, Menotti A, Antonini R, Urbinati G, Baralle FE, Ricci G. A form of familial hypobetalipoproteinemia not due to a mutation in the apolipoproteinB gene. J Intern Med. 1991;229:41-47.
16. Aguilar-Salinas CA, Barren PHR, Parhofer KG, Young SG, Tessereau D, Bateman J, Quinn C, Scholfeld G. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler Thromb Vase Biol. 1995;15:71-80.
17. Krul ES, Parhofer KG, Barren PHR, Wagner RD, Schonfeld G. ApoB-75, a truncation of apolipoprotein-B associated with familial hypobetalipoproteinemia. J Lipid Res. 1992;33:1037-1050.
18. Parhofer KG, Barren PHR, Bier DM, Schonfeld G. Determination of kinetic parameters of apolipoprotein-B metabolism using amino-acids labeled with stable isotopes. J Lipid Res. 1991;32: 1311-1323.
19. Hardman DA, Pullinger CR, Hamilton RL, Kane JP, Malloy MJ. Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia. J Clin Invest. 1991;88: 1722-1729.
20. Parhofer KG, Barrett PH, Bier D, Schonfeld G. Lipoproteins containing the truncated apolipoprotein, apoB-89, are cleared from human plasma more rapidly than apoB-100 containing lipoproteins in vivo. J Clin Invest. 1992;89:1931-1937.
21. Parhofer KG, Barrett PHR, Aguilar-Salinas CA, Schonfeld G. Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in apo-B89, apoB-75, apoB54.8, and apoB-31 heterozygotes. J Lipid Res. 1996;37:844-852.
22. Krul E, Kleinman Y, Kinoshita M, Pfleger B, Oida K, Law A, Scott J, Pease R, Schonfeld G. Regional specificities of monoclonal antihuman apolipoprotein B antibodies. J Lipid Res. 1988:29:937-947.
23. Milne RR, Theolis R Jr, Maurice R, Pease RJ, Weech PK, E Rassart E, Fruchart JC, Scott J, Marcel YL. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J Biol Chem. 1989;264:19754-19760.
24. Parhofer KG, Daugherty A. Kinoshita M, Schonfeld G. Enhanced clearance from plasma of low density lipoproteins containing a truncated apolipoprotein, apoB-89. J Lipid Res. 1990;31:2001-2007.
25. Young SG, Peralta FP, Dubois BW, Curtiss LK, Boyles JK, Witztum JL. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B-100, does not bind to apolipoprotein B,E (low density lipoprotein) receptor. J Biol Chem. 1987;262:16604-16611.
26. Welty FK, Seman L, Yen FT. Purification of the apolipoprotein B67-containing low density lipoprotein particle and its affinity for the low density lipoprotein receptor. J Lipid Res. 1995:36:2622-2629.
27. Groenewegen WA, Averna MR, Pulai J, Krule ES, Schonfeld G. Apolipoprotein B-38.9 does not associate with apo(a) and forms two distinct HDL density particle populations that are larger than HDL. J Lipid Res. 1994;35:1012-1025.
28. Young SG, Hubl ST, Smith RS, Snyder SM, Terdiman JF. Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). J Clin Invest. 1990;85:933-942.
29. McDonald HJ, Ribeiro LP. Ethylene and propylene glycol in the prestaining of lipoproteins for electrophoresis. Clin Chim Acta. 1959;4: 458-459.
30. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 1986;128:417-433.
31. Strobel JL, Baynes JW, Thorpe SR. 1251-glycoconjugate labels for identifying sites of protein catabolism in vivo: effect of structure and chemistry of coupling to protein on label entrapment in cells after protein degradation. Arch Biochem Biophys. 1985;240:635-645.
32. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210.
33. Herman M. SAAM Manual. Washington, DC: US Department of Health, Education, and Welfare, 1978. US Public Health Service publication NIH 78-180.
34. Latimer HB, Sawin PB. Morphogenetic studies of the rabbit. Anat Rec. 1957;129:457-471.
35. Daugherty A, Thorpe SR, Lange LG, Sobel BE, Schonfeld G. Loci of catabolism of β-very low density lipoprotein in vivo delineated with a residualizing label, 1251-dilactitol tyramine. J Biol Chem. 1985; 260:14564-14570.
36. Srivastava NS, Noto D, Averna M, Pulai J, Srivastava RAK, Cole TG, Latour MA, Patterson BW, Schonfeld G. A new apolipoprotein B truncation (apoB-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studies. Metabolism. 1996;145:1296-1304.
37. Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 1993;91:1743-1752.